Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis (Q39447244)

12 September 2017

title

Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis (English)

1 reference

Hormone Replacement Therapy

12 September 2017

1 reference

1 reference

Moghissi KS

1 reference

12 September 2017

Schlaff WD

1 reference

12 September 2017

Olive DL

1 reference

12 September 2017

Skinner MA

1 reference

12 September 2017

Yin H

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

12 September 2017

published in

Fertility and Sterility

1 reference

12 September 2017

1 reference

12 September 2017

1 reference

12 September 2017

page(s)

1056-1062

1 reference

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900086-7

Hormone treatment of endometriosis: the estrogen threshold hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900086-7

Long-term use of the low dose LHRH analogue combined with monthly medroxy-progesterone administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900086-7

Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900086-7

A randomized double blind placebo controlled trial of the effects on bone metabolism of the combination of nafarelin acetate and norethisterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900086-7

Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900086-7

Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900086-7

Revised American Fertility Society classification of endometriosis: 1985

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900086-7

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2898%2900086-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(98)00086-7

1 reference

12 September 2017

1 reference